DOPA pheomelanin is increased in nigral neuromelanin of Parkinson’s disease-Reference-Cited by-同舟云学术

DOPA pheomelanin is increased in nigral neuromelanin of Parkinson’s disease

Published:2023-04 Issue: Volume:223 Page:102414
ISSN:0301-0082
Container-title:Progress in Neurobiology
language:en
Short-container-title:Progress in Neurobiology

Author:

Cai Waijiao,Wakamatsu Kazumasa,Zucca Fabio A.,Wang Qing,Yang Kai,Mohamadzadehonarvar Niyaz,Srivastava Pranay,Tanaka Hitomi,Holly Gabriel,Casella Luigi,Ito Shosuke,Zecca Luigi,Chen Xiqun

Publisher

Elsevier BV

Subject

General Neuroscience

Reference75 articles.

1. Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse;Aoyama;Nat. Neurosci.,2006

2. Neuromelanin MRI - dark substance shines a light on dopamine dysfunction and cocaine use;Bradberry;Am. J. Psychiatry,2020

3. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease;Burbulla;Science,2017

4. The surface oxidation potential of human neuromelanin reveals a spherical architecture with a pheomelanin core and a eumelanin surface;Bush;Proc. Natl. Acad. Sci. USA,2006

5. Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson's disease;Cai;Mol. Neurodegener.,2022

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiological Roles of Eumelanin- and Melanogenesis-Associated Diseases: A Look at the Potentialities of Engineered and Microbial Eumelanin in Clinical Practice;Bioengineering;2024-07-25

2. Oxidation of dopamine and related catechols in dopaminergic brain regions in Parkinson’s disease and during ageing in non-Parkinsonian subjects;Journal of Neural Transmission;2024-01-18

3. Melanin: a unifying theory of disease as exemplified by Parkinson’s, Alzheimer’s, and Lewy body dementia;Frontiers in Immunology;2023-09-29

4. Modelling human brain-wide pigmentation in rodents recapitulates age-related multisystem neurodegenerative deficits;2023-08-08

5. Neuromelanin: Its role in the pathogenesis of idiopathic Parkinson's disease and potential as a therapeutic target;Parkinsonism & Related Disorders;2023-07